Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Indian Pediatr ; 2008 Mar; 45(3): 236-8
Article in English | IMSEAR | ID: sea-12436

ABSTRACT

Voriconazole is a newer systemic antifungal agent effective against Candida and Aspergillus. There are few reports of its safe use in newborns. We report the first case series of safe Voriconazole use in critically ill newborns with cardiac disease along with several other cardiac drugs without any significant drug interaction or side-effect.


Subject(s)
Antifungal Agents/adverse effects , Aspergillosis/drug therapy , Aspergillus/drug effects , Candida/drug effects , Candidiasis/drug therapy , Critical Illness , Humans , Infant, Newborn , Pyrimidines/adverse effects , Triazoles/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL